Selective immunosuppressants

Ultomiris 300 mg/3 mL (100 mg/mL) injection Images

Generic Name: ravulizumab

This medication has been identified as Ultomiris 300 mg/3 mL (100 mg/mL) injection. It is supplied by Alexion Pharmaceuticals Inc.

Ultomiris is used in the treatment of Myasthenia Gravis; Paroxysmal Nocturnal Hemoglobinuria; Hemolytic Uremic Syndrome and belongs to the drug class selective immunosuppressants. Ultomiris 300 mg/3 mL (100 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).

Images

Ultomiris (Ravulizumab [ rav-ue-liz-ue-mab ])-medicine-300 mg/3 mL (100 mg/mL) injection

Ultomiris
Generic Name: ravulizumab [ rav-ue-liz-ue-mab ]
Imprint: medicine
Strength: 300 mg/3 mL (100 mg/mL) injection
Color: N/A
Size: N/A
Shape: N/A
Availability: Prescription only
Drug Class: Selective immunosuppressants
Pregnancy Category: N/A
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 25682-0025
Inactive Ingredients:
Latest News
Related Drugs